Product information

From Health Canada

Current status:

Approved

Current status date:

2008-06-18

Product name:

REACTINE EYE DROPS

DIN:

02237000 Electronic product monograph is not available

Company:

MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
88 Mcnabb Street
Markham
Ontario
Canada L3R 5L2

Class:

Human

Dosage form(s):

Drops

Route(s) of administration:

Ophthalmic

Number of active ingredient(s):

2

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

04:04.20  ,  52:32.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

S01GA51 NAPHAZOLINE, COMBINATIONS

Active ingredient group (AIG) number:See footnote5

0213722002

List of active ingredient(s)
Active ingredient(s) Strength
NAPHAZOLINE HYDROCHLORIDE 0.025 % / W/V
PHENIRAMINE MALEATE 0.3 % / W/V
Version 4.0.2
Date modified: